Today: 27 April 2026
SiTime (SITM) stock price drops 5.5% into weekend as investors focus on insider filing and next earnings
26 January 2026
1 min read

SiTime (SITM) stock price drops 5.5% into weekend as investors focus on insider filing and next earnings

New York, Jan 25, 2026, 20:16 EST — Market closed

SiTime Corp shares dropped 5.5% on Friday, closing at $342.90 and adding to a late-week decline as U.S. markets headed into the weekend. The stock started the day at $363.45, fluctuated between $341.44 and $367.49, and ended down $19.90 on roughly 222,000 shares traded.

Trading won’t resume until Monday, leaving all eyes on SiTime’s next update about demand and margins. Its timing parts power many electronics, yet the stock can swing dramatically when expectations change.

The broader semiconductor sector also dipped. On Friday, the iShares Semiconductor ETF, a key benchmark for chip stocks, dropped 1.1%.

A regulatory filing Friday revealed new director Faraj Aalaei was granted 1,083 restricted stock units (RSUs) — stock awards that usually vest over time instead of being bought outright. The Form 4, which reports insider transactions, recorded the award date as Jan. 21 and showed the shares were issued at $0.

SiTime revealed earlier this week that it has increased its board size to nine directors, naming Aalaei—founder of AI software firm Cognichip—as a Class II director. The filing also confirmed his appointment to the compensation and talent committee.

In a related announcement, CEO Rajesh Vashist highlighted that Aalaei’s background in AI, networking, and communications “aligns with SiTime’s ambitions.” The company also reported that its communications, enterprise, and data center segment has more than doubled year-on-year in each of the last six quarters through Q3. SEC

SiTime positions itself as a precision-timing provider, offering programmable clock and oscillator chips designed to keep signals synchronized across devices from networking equipment to industrial systems. This specialized market gains from demand for faster connections and more precise timing, yet it remains vulnerable to fluctuations in electronics spending.

Still, insider filings linked to director appointments usually reveal more about how compensation is structured than genuine confidence in the stock. The real threat lies in guidance — not governance — shifting investors’ expectations on growth pace and the margin price tag.

Traders will be watching closely to see if Friday’s momentum carries over into Monday, especially to gauge if the chip sector can stabilize after last week’s decline. In this quiet news period, any new filings or company remarks could quickly shift sentiment.

SiTime’s Q4 results drop after the close on Feb. 4, with a conference call set for 2 p.m. Pacific.

Stock Market Today

  • SLV vs. SIVR: Comparing Silver ETFs for Long-Term Investors
    April 27, 2026, 3:49 PM EDT. The silver ETF market features two major players: iShares Silver Trust (SLV) and abrdn Physical Silver Shares ETF (SIVR). Both track physical silver, yet their expense ratios differ significantly. SLV charges 0.5% annually, while SIVR's effective fee is 0.3% due to a fee waiver, making SIVR more cost-effective for long-term investors. Silver prices have surged recently, fueled by increasing demand from renewable energy and data centers. Although SLV manages about $31 billion more in assets than SIVR, investors seeking lower costs may favor SIVR. Fee differences can substantially affect returns over time, making cost a crucial consideration when choosing between these two closely matched silver ETFs.

Latest article

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

27 April 2026
Intellia Therapeutics reported its CRISPR drug lonvo-z cut hereditary angioedema attacks by 87% versus placebo in a late-stage trial, with 62% of treated patients attack- and therapy-free over six months. The company has started a rolling U.S. approval application. No serious adverse events were reported. Intellia shares fell 0.9% to $13.51 after initial gains.
U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

27 April 2026
U.S. Energy Corp. signed a five-year helium sales deal with an unnamed global industrial gas company, securing a buyer for output from its planned Big Sky Carbon Hub in Montana. The contract covers up to 1.2 million cubic feet a month at a fixed $285 per thousand cubic feet, with inflation adjustments starting March 2028. U.S. Energy shares rose 20.8% to $1.12 on heavy volume. The agreement is “take-or-pay,” with the buyer handling pickup at the plant.
Veradermics Stock Jumps After VDPHL01 Hair-Loss Pill Hits Trial Goals

Veradermics Stock Jumps After VDPHL01 Hair-Loss Pill Hits Trial Goals

27 April 2026
Veradermics shares rose 40% Monday after its oral hair-loss drug VDPHL01 met all main goals in a Phase 2/3 trial of 519 men. Patients taking the drug saw average hair count increases of 30.3 to 33.0 hairs per square centimeter over six months, compared to 7.3 for placebo. No treatment-related serious or heart-related adverse events were reported.
OmniVision Integrated Circuits (603501) stock: Monday’s Shanghai open in focus after Nvidia China trip report
Previous Story

OmniVision Integrated Circuits (603501) stock: Monday’s Shanghai open in focus after Nvidia China trip report

Singapore stocks hit a record as UOB, OCBC rally — and SGX’s lot-size cut plan is back in play
Next Story

Singapore stocks hit a record as UOB, OCBC rally — and SGX’s lot-size cut plan is back in play

Go toTop